Plain-English translation of NCT06932614 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer treatment called Lyophilized Self Growth Factor (SRF) works better than the more commonly used Platelet-Rich Plasma (PRP) for knee arthritis. Both treatments use substances made from your own blood that are thought to help repair damaged knee tissue. The study will compare these two approaches head-to-head, plus a control group that receives a salt-water injection.
Knee arthritis causes pain and stiffness that can really limit how much people can do, and current treatments like pain medications or steroids don't always work well or can have side effects. Researchers want to test whether this new treatment might be more effective and help people recover faster.
You likely qualify if…
You likely don't qualify if…
You will receive three injections directly into your knee—one per month for three months. You'll visit the clinic before treatment starts, then return for follow-up visits at 1, 2, 3, and 6 months after your injections to see how well the treatment is working. The study uses surveys and pain scales to measure how much your knee pain and stiffness improve over time.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Taiwan